[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Injectable Drugs Consumption Market Report

September 2018 | 137 pages | ID: 2D858A18DD7EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Injectable Drugs market for 2018-2023.

Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Over the next five years, LPI(LP Information) projects that Injectable Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Biologics
  • Small molecules
Segmentation by application:
  • Auto-immune diseases
  • Hormonal Disorders
  • Orphan Diseases
  • Oncology
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi
  • ...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Injectable Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Injectable Drugs market by identifying its various subsegments.
  • Focuses on the key global Injectable Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Injectable Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Injectable Drugs submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Injectable Drugs Consumption 2013-2023
  2.1.2 Injectable Drugs Consumption CAGR by Region
2.2 Injectable Drugs Segment by Type
  2.2.1 Biologics
  2.2.2 Small molecules
2.3 Injectable Drugs Consumption by Type
  2.3.1 Global Injectable Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Injectable Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Injectable Drugs Sale Price by Type (2013-2018)
2.4 Injectable Drugs Segment by Application
  2.4.1 Auto-immune diseases
  2.4.2 Hormonal Disorders
  2.4.3 Orphan Diseases
  2.4.4 Oncology
2.5 Injectable Drugs Consumption by Application
  2.5.1 Global Injectable Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Injectable Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Injectable Drugs Sale Price by Application (2013-2018)

3 GLOBAL INJECTABLE DRUGS BY PLAYERS

3.1 Global Injectable Drugs Sales Market Share by Players
  3.1.1 Global Injectable Drugs Sales by Players (2016-2018)
  3.1.2 Global Injectable Drugs Sales Market Share by Players (2016-2018)
3.2 Global Injectable Drugs Revenue Market Share by Players
  3.2.1 Global Injectable Drugs Revenue by Players (2016-2018)
  3.2.2 Global Injectable Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Injectable Drugs Sale Price by Players
3.4 Global Injectable Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Injectable Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Injectable Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 INJECTABLE DRUGS BY REGIONS

4.1 Injectable Drugs by Regions
  4.1.1 Global Injectable Drugs Consumption by Regions
  4.1.2 Global Injectable Drugs Value by Regions
4.2 Americas Injectable Drugs Consumption Growth
4.3 APAC Injectable Drugs Consumption Growth
4.4 Europe Injectable Drugs Consumption Growth
4.5 Middle East & Africa Injectable Drugs Consumption Growth

5 AMERICAS

5.1 Americas Injectable Drugs Consumption by Countries
  5.1.1 Americas Injectable Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Injectable Drugs Value by Countries (2013-2018)
5.2 Americas Injectable Drugs Consumption by Type
5.3 Americas Injectable Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Injectable Drugs Consumption by Countries
  6.1.1 APAC Injectable Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Injectable Drugs Value by Countries (2013-2018)
6.2 APAC Injectable Drugs Consumption by Type
6.3 APAC Injectable Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Injectable Drugs by Countries
  7.1.1 Europe Injectable Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Injectable Drugs Value by Countries (2013-2018)
7.2 Europe Injectable Drugs Consumption by Type
7.3 Europe Injectable Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Injectable Drugs by Countries
  8.1.1 Middle East & Africa Injectable Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Injectable Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Injectable Drugs Consumption by Type
8.3 Middle East & Africa Injectable Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Injectable Drugs Distributors
10.3 Injectable Drugs Customer

11 GLOBAL INJECTABLE DRUGS MARKET FORECAST

11.1 Global Injectable Drugs Consumption Forecast (2018-2023)
11.2 Global Injectable Drugs Forecast by Regions
  11.2.1 Global Injectable Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Injectable Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Injectable Drugs Forecast by Type
11.8 Global Injectable Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AbbVie
  12.1.1 Company Details
  12.1.2 Injectable Drugs Product Offered
  12.1.3 AbbVie Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AbbVie News
12.2 F. Hoffmann-La Roche
  12.2.1 Company Details
  12.2.2 Injectable Drugs Product Offered
  12.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 F. Hoffmann-La Roche News
12.3 GlaxoSmithKline
  12.3.1 Company Details
  12.3.2 Injectable Drugs Product Offered
  12.3.3 GlaxoSmithKline Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 GlaxoSmithKline News
12.4 Sanofi
  12.4.1 Company Details
  12.4.2 Injectable Drugs Product Offered
  12.4.3 Sanofi Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Sanofi News

...

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Injectable Drugs
Table Product Specifications of Injectable Drugs
Figure Injectable Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Injectable Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Injectable Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Injectable Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Biologics
Table Major Players of Biologics
Figure Product Picture of Small molecules
Table Major Players of Small molecules
Table Global Consumption Sales by Type (2013-2018)
Table Global Injectable Drugs Consumption Market Share by Type (2013-2018)
Figure Global Injectable Drugs Consumption Market Share by Type (2013-2018)
Table Global Injectable Drugs Revenue by Type (2013-2018) ($ million)
Table Global Injectable Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Injectable Drugs Value Market Share by Type (2013-2018)
Table Global Injectable Drugs Sale Price by Type (2013-2018)
Figure Injectable Drugs Consumed in Auto-immune diseases
Figure Global Injectable Drugs Market: Auto-immune diseases (2013-2018) (K Units)
Figure Global Injectable Drugs Market: Auto-immune diseases (2013-2018) ($ Millions)
Figure Global Auto-immune diseases YoY Growth ($ Millions)
Figure Injectable Drugs Consumed in Hormonal Disorders
Figure Global Injectable Drugs Market: Hormonal Disorders (2013-2018) (K Units)
Figure Global Injectable Drugs Market: Hormonal Disorders (2013-2018) ($ Millions)
Figure Global Hormonal Disorders YoY Growth ($ Millions)
Figure Injectable Drugs Consumed in Orphan Diseases
Figure Global Injectable Drugs Market: Orphan Diseases (2013-2018) (K Units)
Figure Global Injectable Drugs Market: Orphan Diseases (2013-2018) ($ Millions)
Figure Global Orphan Diseases YoY Growth ($ Millions)
Figure Injectable Drugs Consumed in Oncology
Figure Global Injectable Drugs Market: Oncology (2013-2018) (K Units)
Figure Global Injectable Drugs Market: Oncology (2013-2018) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Injectable Drugs Consumption Market Share by Application (2013-2018)
Figure Global Injectable Drugs Consumption Market Share by Application (2013-2018)
Table Global Injectable Drugs Value by Application (2013-2018)
Table Global Injectable Drugs Value Market Share by Application (2013-2018)
Figure Global Injectable Drugs Value Market Share by Application (2013-2018)
Table Global Injectable Drugs Sale Price by Application (2013-2018)
Table Global Injectable Drugs Sales by Players (2016-2018) (K Units)
Table Global Injectable Drugs Sales Market Share by Players (2016-2018)
Figure Global Injectable Drugs Sales Market Share by Players in 2016
Figure Global Injectable Drugs Sales Market Share by Players in 2017
Table Global Injectable Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Injectable Drugs Revenue Market Share by Players (2016-2018)
Figure Global Injectable Drugs Revenue Market Share by Players in 2016
Figure Global Injectable Drugs Revenue Market Share by Players in 2017
Table Global Injectable Drugs Sale Price by Players (2016-2018)
Figure Global Injectable Drugs Sale Price by Players in 2017
Table Global Injectable Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Injectable Drugs Products Offered
Table Injectable Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Injectable Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Injectable Drugs Consumption Market Share by Regions 2013-2018
Figure Global Injectable Drugs Consumption Market Share by Regions 2013-2018
Table Global Injectable Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Injectable Drugs Value Market Share by Regions 2013-2018
Figure Global Injectable Drugs Value Market Share by Regions 2013-2018
Figure Americas Injectable Drugs Consumption 2013-2018 (K Units)
Figure Americas Injectable Drugs Value 2013-2018 ($ Millions)
Figure APAC Injectable Drugs Consumption 2013-2018 (K Units)
Figure APAC Injectable Drugs Value 2013-2018 ($ Millions)
Figure Europe Injectable Drugs Consumption 2013-2018 (K Units)
Figure Europe Injectable Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Injectable Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Injectable Drugs Value 2013-2018 ($ Millions)
Table Americas Injectable Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Injectable Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Injectable Drugs Consumption Market Share by Countries in 2017
Table Americas Injectable Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Injectable Drugs Value Market Share by Countries (2013-2018)
Figure Americas Injectable Drugs Value Market Share by Countries in 2017
Table Americas Injectable Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Injectable Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Injectable Drugs Consumption Market Share by Type in 2017
Table Americas Injectable Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Injectable Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Injectable Drugs Consumption Market Share by Application in 2017
Figure United States Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Injectable Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Injectable Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Injectable Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Injectable Drugs Consumption Market Share by Countries in 2017
Table APAC Injectable Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Injectable Drugs Value Market Share by Countries (2013-2018)
Figure APAC Injectable Drugs Value Market Share by Countries in 2017
Table APAC Injectable Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Injectable Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Injectable Drugs Consumption Market Share by Type in 2017
Table APAC Injectable Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Injectable Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Injectable Drugs Consumption Market Share by Application in 2017
Figure China Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure China Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure India Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure India Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Injectable Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Injectable Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Injectable Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Injectable Drugs Consumption Market Share by Countries in 2017
Table Europe Injectable Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Injectable Drugs Value Market Share by Countries (2013-2018)
Figure Europe Injectable Drugs Value Market Share by Countries in 2017
Table Europe Injectable Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Injectable Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Injectable Drugs Consumption Market Share by Type in 2017
Table Europe Injectable Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Injectable Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Injectable Drugs Consumption Market Share by Application in 2017
Figure Germany Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure France Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure France Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Injectable Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Injectable Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Injectable Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Injectable Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Injectable Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Injectable Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Injectable Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Injectable Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Injectable Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Injectable Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Injectable Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Injectable Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Injectable Drugs Consumption Market Share by Application in 2017
Figure Egypt Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Injectable Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Injectable Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Injectable Drugs Value Growth 2013-2018 ($ Millions)
Table Injectable Drugs Distributors List
Table Injectable Drugs Customer List
Figure Global Injectable Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Injectable Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Injectable Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Injectable Drugs Consumption Market Forecast by Regions
Table Global Injectable Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Injectable Drugs Value Market Share Forecast by Regions
Figure Americas Injectable Drugs Consumption 2018-2023 (K Units)
Figure Americas Injectable Drugs Value 2018-2023 ($ Millions)
Figure APAC Injectable Drugs Consumption 2018-2023 (K Units)
Figure APAC Injectable Drugs Value 2018-2023 ($ Millions)
Figure Europe Injectable Drugs Consumption 2018-2023 (K Units)
Figure Europe Injectable Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Injectable Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Injectable Drugs Value 2018-2023 ($ Millions)
Figure United States Injectable Drugs Consumption 2018-2023 (K Units)
Figure United States Injectable Drugs Value 2018-2023 ($ Millions)
Figure Canada Injectable Drugs Consumption 2018-2023 (K Units)
Figure Canada Injectable Drugs Value 2018-2023 ($ Millions)
Figure Mexico Injectable Drugs Consumption 2018-2023 (K Units)
Figure Mexico Injectable Drugs Value 2018-2023 ($ Millions)
Figure Brazil Injectable Drugs Consumption 2018-2023 (K Units)
Figure Brazil Injectable Drugs Value 2018-2023 ($ Millions)
Figure China Injectable Drugs Consumption 2018-2023 (K Units)
Figure China Injectable Drugs Value 2018-2023 ($ Millions)
Figure Japan Injectable Drugs Consumption 2018-2023 (K Units)
Figure Japan Injectable Drugs Value 2018-2023 ($ Millions)
Figure Korea Injectable Drugs Consumption 2018-2023 (K Units)
Figure Korea Injectable Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Injectable Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Injectable Drugs Value 2018-2023 ($ Millions)
Figure India Injectable Drugs Consumption 2018-2023 (K Units)
Figure India Injectable Drugs Value 2018-2023 ($ Millions)
Figure Australia Injectable Drugs Consumption 2018-2023 (K Units)
Figure Australia Injectable Drugs Value 2018-2023 ($ Millions)
Figure Germany Injectable Drugs Consumption 2018-2023 (K Units)
Figure Germany Injectable Drugs Value 2018-2023 ($ Millions)
Figure France Injectable Drugs Consumption 2018-2023 (K Units)
Figure France Injectable Drugs Value 2018-2023 ($ Millions)
Figure UK Injectable Drugs Consumption 2018-2023 (K Units)
Figure UK Injectable Drugs Value 2018-2023 ($ Millions)
Figure Italy Injectable Drugs Consumption 2018-2023 (K Units)
Figure Italy Injectable Drugs Value 2018-2023 ($ Millions)
Figure Russia Injectable Drugs Consumption 2018-2023 (K Units)
Figure Russia Injectable Drugs Value 2018-2023 ($ Millions)
Figure Spain Injectable Drugs Consumption 2018-2023 (K Units)
Figure Spain Injectable Drugs Value 2018-2023 ($ Millions)
Figure Egypt Injectable Drugs Consumption 2018-2023 (K Units)
Figure Egypt Injectable Drugs Value 2018-2023 ($ Millions)
Figure South Africa Injectable Drugs Consumption 2018-2023 (K Units)
Figure South Africa Injectable Drugs Value 2018-2023 ($ Millions)
Figure Israel Injectable Drugs Consumption 2018-2023 (K Units)
Figure Israel Injectable Drugs Value 2018-2023 ($ Millions)
Figure Turkey Injectable Drugs Consumption 2018-2023 (K Units)
Figure Turkey Injectable Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Injectable Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Injectable Drugs Value 2018-2023 ($ Millions)
Table Global Injectable Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Injectable Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Injectable Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Injectable Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Injectable Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Injectable Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Injectable Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Injectable Drugs Value Market Share Forecast by Application (2018-2023)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Injectable Drugs Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Injectable Drugs Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Injectable Drugs Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Injectable Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Injectable Drugs Market Share (2016-2018)


More Publications